PlainRecalls
FDA Drug Low Class III Terminated

BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets per bottle, Rx only, Distributed by: Actavis South Atlantic, LLC, Sunrise, FL 33325; Packaged by: American Health Packaging, Columbus, OH 43217, NDC 67767-142-30, UPC 3 67767-142-30 6.

Reported: August 14, 2013 Initiated: July 31, 2013 #D-855-2013

Product Description

BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets per bottle, Rx only, Distributed by: Actavis South Atlantic, LLC, Sunrise, FL 33325; Packaged by: American Health Packaging, Columbus, OH 43217, NDC 67767-142-30, UPC 3 67767-142-30 6.

Reason for Recall

Failed Dissolution Specifications: Dissolution test results at 8 hour time-point were above approved specification limits.

Details

Recalling Firm
Actavis Inc
Units Affected
15,132 bottles
Distribution
Nationwide and Puerto Rico
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets per bottle, Rx only, Distributed by: Actavis South Atlantic, LLC, Sunrise, FL 33325; Packaged by: American Health Packaging, Columbus, OH 43217, NDC 67767-142-30, UPC 3 67767-142-30 6.. Recalled by Actavis Inc. Units affected: 15,132 bottles.
Why was this product recalled?
Failed Dissolution Specifications: Dissolution test results at 8 hour time-point were above approved specification limits.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 14, 2013. Severity: Low. Recall number: D-855-2013.